TrialJournal of neurology2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.
T L Vollmer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled ittrialcites it